More on RGNX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.07 |
|
|||
| Open | $8.94 | ||||
| 52 Wk High | $25.00 | ||||
| 52 Wk Low | $7.07 | ||||
| Day High | $10.34 | ||||
| Day Low | $8.94 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,968,216 | ||||
- H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
- Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- FDA aligns with Regenxbio on path to refile MPS II gene therapy BLA
- REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Gene Therapy for MPS II
- Regenxbio shares jump after FDA agrees to reverse drug rejection
- Regenxbio Inc. (RGNX) PT Lowered to $26 at H.C. Wainwright
- Form SCHEDULE 13G/A REGENXBIO Inc. Filed by: JPMORGAN CHASE & CO
- Form SC TO-I REGENXBIO Inc. Filed by: REGENXBIO Inc.
- Form 8-K REGENXBIO Inc. For: May 29
Entities mentioned with RGNX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Morgan Stanley | View Related Stories »
- Show More...
